| 博思清与维思通治疗精神分裂症的药物经济学分析 |
| |
| 引用本文： | 李晶武. 博思清与维思通治疗精神分裂症的药物经济学分析[J]. 中国药物经济学, 2012, 0(5): 6-7 |
| |
| 作者姓名： | 李晶武 |
| |
| 作者单位： | 辽宁省辽阳市第四人民医院,辽宁辽阳 111000 |
| |
| 摘 要： | 目的比较博思清与维思通治疗精神分裂症的成本-效果。方法对50例住院精神分裂症患者应用博思清与维思通进行治疗,疗程6周。采用成本-效果分析法对两组进行分析。结果博思清与维思通治疗精神分裂症的有效率分别为96.0%和92.0%,两者疗效无显著性差异(P>0.05),成本分别为638.16元和647.8元。结论博思清治疗精神分裂症疗效与维思通相当,但起效更快,博思清(阿立哌唑)治疗精神分裂症较经济。
|
| 关 键 词： | 博思清 维思通 精神分裂症 |
Pharmacoeconomic analysis of Booz clear and Risperidone in the treatment of schizophrenia |
| |
| Li Jingwu. Pharmacoeconomic analysis of Booz clear and Risperidone in the treatment of schizophrenia[J]. China Journal of Pharmaceutical Economics, 2012, 0(5): 6-7 |
| |
| Authors: | Li Jingwu |
| |
| Abstract: | Objective To compare the Aripirazole and the cost of Risperidone in the treatment of sctfizophreniaresults.Methods 50 hospitalized patients with schizophrenia with Risperidone,Aripirazole treatment,treatment for 6 weeks.Using the cost-effectiveness analysis of 2 groups were analyzed.Results Aripirazole and Risperidone in the treatment of schizophrenia rates were between 96.0% and 92.0%,no significant difference in efficacy（P0.05）,the cost,was 638.16 yuan and 647.8 yuan.Conclusion The efficacy of the treatment of schizophrenia Aripirazole,Risperidone equivalent,but faster onset,Aripirazole in the treatment of schizophrenia than the economy. |
| |
| Keywords: | Aripirazole Risperidone Schizophrenia |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
